The Globe and Mail reports in its Friday, Sept. 25, edition that Raymond James analyst Frederic Bastien is keeping his "outperform" call on Dexterra Group intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Bastien gave his share target a $1.50 boost to $20. Analysts on average target the shares at $18.88. In a client report titled A Defensive-Offensive Compounder Hiding in Plain Sight Mr. Bastien says: "We reaffirm our constructive stance on Dexterra Group after marketing CEO Mark Becker and CFO Denise Achonu [met with] Montreal-based investors this week. The meetings reinforced our view that Dexterra occupies an attractive 'defensive-offensive' position within a portfolio, pairing the recurring cash flows of support services with direct exposure to Canada's multiyear Nation Building, resource and defence investment cycle. Importantly, Dexterra can pursue this growth without abandoning its capital-light model, creating an increasingly attractive combination of earnings durability, organic growth, and capital efficiency. Given our belief this mix warrants a higher valuation than the market currently assigns the company, we are increasing our target price."